Bacterial and fungal superinfections in critically ill patients with COVID-19
- PMID: 32902729
- PMCID: PMC7479998
- DOI: 10.1007/s00134-020-06219-8
Bacterial and fungal superinfections in critically ill patients with COVID-19
Conflict of interest statement
None.
Figures

References
-
- Ibn Saied W, Souweine B, Garrouste-Orgeas M, Ruckly S, Darmon M, Bailly S, Cohen Y, Azoulay E, Schwebel C, Radjou A, Kallel H, Adrie C, Dumenil AS, Argaud L, Marcotte G, Jamali S, Papazian L, Goldgran-Toledano D, Bouadma L, Timsit JF, Group Os Respective impact of implementation of prevention strategies, colonization with multiresistant bacteria and antimicrobial use on the risk of early- and late-onset VAP: an analysis of the OUTCOMEREA network. PLoS One. 2017;12:e0187791. doi: 10.1371/journal.pone.0187791. - DOI - PMC - PubMed
-
- Bassetti M, Giacobbe DR, Grecchi C, Rebuffi C, Zuccaro V, Scudeller L, Investigators F Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, adult patients: a systematic review with qualitative evidence synthesis. J Infect. 2020;81:131–146. doi: 10.1016/j.jinf.2020.03.065. - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources